News | Implantable Cardioverter Defibrillator (ICD) | August 03, 2015

Biotronik Introduces First 3 Tesla MRI-Compatible Pacemakers and Implantable Cardioverter Defibrillators

ProMRI technology allows patients to undergo MRI scans without causing complications with ICDs or pacemakers
 

Biotronik, CE approval, 3T MRI scanning, pacemakers, ICDs

August 3, 2015 — Biotronik announced CE approval of 3 Tesla (T) magnetic resonance imaging (MRI) scanning with exclusion zone for its two latest generations of pacemakers. The company now offers both implantable cardioverter-defibrillators (ICDs) and pacemakers approved for 3T scans.

Roughly 20-30 percent of all MRI scanners installed worldwide are 3T. However, sales of these are growing three times faster than those of 1.5 T scanners.

"The benefits of 3T MRI scanners are clear," commented Maurizio Lunati, M.D., Niguarda Hospital, Milan, Italy. "3T scanners offer superior image quality, as well as a shorter scan time compared to a 1.5T machine. Patients with ProMRI devices enabling 3T scans benefit from a shorter time spent in the sometimes uncomfortable MRI machine, while doctors benefit from clearer images to diagnose conditions. Reduced scan times can improve clinical workflow, granting more patients access to this vital diagnostic tool."

To help physicians keep track of which ProMRI devices and leads are approved in their own region, new functions have been added to the ProMRI Systems Check website. ProMRI System Check allows physicians to verify whether a patient's individual Biotronik device and lead combination is MR conditional, and under which scanning conditions. It is now available in five languages.

For more information: www.biotronik.com


Related Content

News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Home February 21, 2024
Home
News | Magnetic Resonance Imaging (MRI)

November 17, 2023 — Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy ...

Home November 17, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 28, 2023 — Liver disease, the UK’s third leading cause of premature death, poses a significantly greater threat to ...

Home June 28, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 20, 2023 — The US Food and Drug Administration has approved the use of iTFlow in blood flow analysis. The FDA ...

Home June 20, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 7, 2023 — GE HealthCare announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based ...

Home June 07, 2023
Home
Feature | Magnetic Resonance Imaging (MRI) | By Johnson Polakkal Joseph

Magnetic resonance imaging (MRI) is a technology that has been around for more than four decades and is a staple in ...

Home May 01, 2023
Home
News | Magnetic Resonance Imaging (MRI)

April 18, 2023 — Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting ...

Home April 18, 2023
Home
News | Magnetic Resonance Imaging (MRI)

April 4, 2023 — Medtronic has announced the launch of MRI Care Pathway, a new system that can streamline the process of ...

Home April 04, 2023
Home
News | Magnetic Resonance Imaging (MRI)

November 17, 2022 — HeartVista, a pioneer in AI-assisted MRI solutions, and Siemens Healthineers, a global leader in ...

Home November 17, 2022
Home
News | Magnetic Resonance Imaging (MRI)

November 9, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), left ...

Home November 09, 2022
Home
Subscribe Now